Y-Intercept (HK)’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.11M | Buy |
+211,032
| New | +$9.11M | 0.22% | 84 |
|
|
2025
Q1 | – | Sell |
-25,980
| Closed | -$713K | – | 1202 |
|
|
2024
Q4 | $713K | Buy |
25,980
+12,701
| +96% | +$349K | 0.05% | 571 |
|
|
2024
Q3 | $338K | Buy |
+13,279
| New | +$338K | 0.02% | 963 |
|
|
2024
Q1 | – | Sell |
-26,192
| Closed | -$1.06M | – | 1371 |
|
|
2023
Q4 | $1.06M | Buy |
26,192
+11,988
| +84% | +$484K | 0.1% | 297 |
|
|
2023
Q3 | $375K | Buy |
+14,204
| New | +$375K | 0.04% | 674 |
|
|
2022
Q4 | – | Sell |
-20,217
| Closed | -$201K | – | 1001 |
|
|
2022
Q3 | $201K | Buy |
+20,217
| New | +$201K | 0.02% | 823 |
|